Information updates

New MBS item numbers for allergy testing – effective 1 November 2018

31 October 2018

New Medicare Benefits Schedule (MBS) item numbers for allergy testing are effective as of 1 November 2018. The following are responses to questions that ASCIA has recently received about the new MBS item numbers:

  • MBS item numbers 12000 and 12003 can be co-claimed on the same day, but MBS item number 12000 is restricted to specialists or consultant physicians, which includes paediatricians. 
  • MBS item numbers 12001 and 12002 are each limited to one claim per 12 month period, but they are not restricted to specialists or consultant physicians. 
  • These MBS item number changes for allergy testing were not initiated by ASCIA. However, in response to a 2017 submission by ASCIA, the item numbers were significantly modified, to ensure patients with complex allergies are not disadvantaged. 
  • The changes were made as part of the MBS review into allergy skin testing item numbers and are explained on the MBS website: www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Factsheet-DermatologyAllergy

ASCIA has developed a Scope of Practice document that includes a summary of the new MBS item numbers and is available open access on the ASCIA website: www.allergy.org.au/ascia-reports  

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information.Verify here.